![](/-/media/images/shared/people/j/jn-jz/joseph_joshua-j_720x720.jpg?la=en&hash=AB8C92CA9FBF8C12E3B3686DDF15E1B7)
Ohio State study shows socioeconomic status may be an uneven predictor of heart health
More than 40 physicians and researchers from The Ohio State University Wexner Medical Center participated in the 2023 American Heart Association Scientific Sessions in Philadelphia, an annual conference that attracts thousands of experts from around the world to discuss the latest research on reducing the impact of cardiovascular disease. More than 30 Ohio State researchers or physicians served as panelists, moderators or gave poster presentations during this year’s Scientific Sessions.
Kristin Stanford, PhD, Associate Director of the Davis Heart & Lung Research Institute, highlights the Ohio State Wexner Medical Center's participation in the 2023 AHA Scientific Session.
More than 275 news articles appeared in major media outlets and trade publications nationwide and around the world, highlighting research done by Ohio State experts or their perspective on research conducted by other institutions.
Chief Executive Officer of The Ohio State University Wexner Medical Center
Executive Vice President at Ohio State
Director, Division of Human Genetics
Professor of Internal Medicine
Director, Electrophysiology Research Section Professor of Cardiovascular Medicine – Clinical
Associate Professor of Internal Medicine
Division of Endocrinology, Diabetes and Metabolism
Director, Preventative Cardiology and Women’s Health
Sarah Ross Soter Endowed Chair for Women’s Cardiovascular Health Research
Associate Director, Davis Heart and Lung Research Institute
Associate Director, Diabetes and Metabolism Research Center
“At the Davis Heart and Lung Research Institute, we applaud our outstanding faculty and trainees participating in this year’s American Heart Association Scientific Sessions, the premier showcase for the latest breakthroughs in cardiovascular research and patient care. I’m thrilled about representation of The Ohio State University at this year’s meeting, with exciting presentations on a broad range of topics from novel mechanisms of disease to new diagnostic technologies to innovative community outreach efforts. Together, our physicians, basic scientists and engineers are building a bridge to a brighter future for patients with cardiovascular disease in Ohio and around the world.”
Learn more about the Davis Heart and Lung Research Institute
Ohio State study shows socioeconomic status may be an uneven predictor of heart health
Benefit of routine genetic testing of dilated cardiomyopathy patients with advanced heart disease
$4.3 million grant will study heart health impacts of chronic stress
Heart researcher takes on unlikely disease: cancer
For full event details, the AHA Online Program Planner and AHA Conferences App, visit the AHA event webpage.
The choice for heart and vascular care is clear